TheraRadar
← Back
Data updated: Mar 29, 2026

ESJAY PHARMA

MetabolicInfectious DiseaseNeurology
Big Pharma

ESJAY PHARMA is a major pharmaceutical company focused on Metabolic, Infectious Disease, Neurology.

1941
Since
5
Drugs
-
Trials
12
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

FUROSEMIDE 2026-01-08
FUROSEMIDE 2025-09-12
Labeling
FUROSEMIDE 2025-09-08
Labeling
FUROSEMIDE 2025-08-06
Labeling
FUROSEMIDE 2025-07-17
FUROSEMIDE 2025-05-08
Labeling
FUROSEMIDE 2024-12-13
FUROSEMIDE 2024-10-01
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Metabolic 50%
2 drugs
Infectious Disease 25%
1 drugs
Neurology 25%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Novo Nordisk big-pharma
Metabolic, Infectious Disease, Neurology
AZURITY specialty
Neurology, Metabolic, Infectious Disease
ABBOTT big-pharma
Infectious Disease, Neurology, Metabolic
Merck big-pharma
Infectious Disease, Metabolic
AbbVie big-pharma
Neurology, Infectious Disease